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Abstract
Thyroid hormone importantly affects the cardiovascular system. However,
evaluation of stroke volume (SV) and its determinants is confounded by vari-
ations in volume status that occur along different thyroid states. This study
applied the pressure-volume (PV) framework to obtain relatively load-inde-
pendent estimates of cardiac function in hypothyroidism as compared to
euthyroidism. Ten athyroid patients were assessed echocardiographically after
4 weeks in deep hypothyroid state, and again after supplementation with oral
Levothyroxine (LT4) for 3 months. Thyroid hormone levels were assessed and
noninvasive pressure-volume (PV) analysis based on dedicated repeated
echocardiograms was performed. Changes were assessed using paired tests.
Results are presented as medians and interquartile ranges. Hypothyroidism
was associated with reduced stroke volume (SV: 67.6  17 vs.
75.7  20.6 mL, P = 0.024), preload (end-diastolic volume, EDV:
122.6  32.5 vs. 135.7  33.6 mL, P = 0.004), and contractility (end-systolic
elastance, Ees: 1.7  0.33 vs. 2.58  1.33 mmHg/mL, P = 0.01). Afterload was
constant (effective arterial elastance, Ea: 1.66  0.32 vs. 1.79  0.52 mmHg/
mL, P = 0.43) and the total energy spent was lower (PVA∙HR: 86.7  28 vs.
110.9  32.1 J, P = 0.04). Hemodynamic manifestations of frank hypothy-
roidism in humans are characterized by reduced preload and contractility, and
unchanged total afterload. LT4 therapy increased work efficiency and heart
rate, but not the net energy expenditure. Noninvasive PV analysis may be use-
ful to follow-up different thyroid states.
Introduction
Thyroid hormone (TH) has important cardiovascular
effects. Thyroid dysfunction is a well-recognized risk fac-
tor for many cardiovascular diseases. Hyperthyroidism is
associated with increased risk of atrial fibrillation (AF) as
well as sudden cardiac death (Collet et al. 2012; Chaker
et al. 2016). Thyroid storm is an endocrine emergency
because of the risk of cardiac failure. Hypothyroidism is
associated with an increased risk of coronary heart disease
events and mortality (Cappola and Ladenson 2003;
Rodondi et al. 2010).
The pathophysiological mechanisms behind these clini-
cal well-established associations are not fully elucidated.
The chronotropic effects of TH underlie the presence of
sinus tachycardia at rest and occasionally AF in hyperthy-
roidism. Left ventricle (LV) hypertrophy and left atrium
(LA) enlargement are part of the initial manifestations of
hyperthyroidism, later progressing to rate-related systolic
dysfunction if left untreated (Iwasaki et al. 1989).
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Furthermore, hyperthyroid patients, whose cardiac output
(CO) tends to be on average 50–300% above normal,
often have systolic hypertension (Klein and Ojamaa
2001). At the metabolic level, a less efficient use of the
products of oxidative metabolism leads to energetic deficit
and oxidative stress while facing the higher demands
posed by this hyperdynamic state (Maity et al. 2013). In
contrast, the abovementioned effects are mostly the oppo-
site in hypothyroidism, including reduced CO and eleva-
tion of the diastolic blood pressure relative to systolic.
Ventricular ejection time (ET), stroke volume (SV), end-
diastolic volume (EDV), and circulating blood volume
tend to decrease (Wieshammer et al. 1988; Monzani et al.
2001).
The assessment of the physiological effects of TH on
the circulation faces several difficulties. Evaluation of the
contractile function in thyroid dysfunction is confounded
by variations in volume status occurring along the serial
assessments under different thyroid states. Diverse studies
have attempted to assess the determinants of the hypody-
namic state in hypothyroidism, with only partial repro-
ducibility of results (Forfar et al. 1985; Wieshammer et al.
1988; Monzani et al. 2001; Hoftijzer et al. 2009). One
study documented increases in the maximal systolic elas-
tance (Emax) in subclinical hypothyroidism following
subtotal thyroidectomy, but used vasodilators on the pro-
cess and hence could not draw conclusions on the after-
load (Forfar et al. 1985). One second study on
hypothyroidism reported no increase in Emax, but 44% of
the nine patients of this study were not in hypothy-
roidism during the measurements (Wieshammer et al.
1988). Notwithstanding, in vitro and animal studies con-
sistently reported TH to have biomolecular mechanisms
that influence contractility (Taylor et al. 1969; Strauer
and Schulze 1976).
The pressure-volume (PV) framework is a time-vary-
ing elastance model inspired on Otto Frank‘s first
descriptions of the cardiac PV relations in conjunction
with Starling‘s Law of the Heart, Sarnoff‘s ventricular
function curve, and Sonnenblick‘s force–velocity curve.
Inferences on contractility were firstly validated in
canine excised hearts by H. Suga in 1969 and later
extended to ventricular energetics. Based on these devel-
opments, the Emax and the pressure-volume area (PVA)
became widely popular as load-independent indices of
the cardiac function. When used invasively, the PV
framework is today the gold standard for evaluating the
cardiac function as it minimizes the effects of variations
in loading conditions over the estimations. Further
ahead, single-beat algorithms developed to estimate sys-
tolic and diastolic relations extended the framework
reach to the noninvasive spectra (Chen et al. 2001;
Klotz et al. 2006).
This is an interesting perspective in the context of the
cardiac effects of THs. Most studies on this regard lacked
load-independent estimates of cardiac function or applied
it partially. The present study provides the first noninva-
sive load-independent evaluation of cardiac function
using state-of-the-art PV analysis in patients exposed to a
standardized period of deep hypothyroidism followed by
thyroxine (LT4) supplementation.
Methods
Subjects
Patients of 18–70 years old with differentiated thyroid
cancer (DTC) were recruited from the outpatient clinic of
the Erasmus Medical Center Rotterdam, between June
2015 and March 2016. Initial therapy consisted of total
thyroidectomy. Patients were eligible for inclusion if they
were scheduled for ablation with radioactive iodine (RAI)
and did not have heart failure or drugs interfering with
TH metabolism. The first measurement was scheduled
after 4 weeks off LT4 (i.e., LT4 withdrawal before RAI
ablation) and the second measurement after 3 months on
LT4 replacement therapy once TSH (thyroid-stimulating
hormone) suppression was reached. The Medical Ethics
Committee of the Erasmus Medical Center approved the
study protocol (MEC-2014-489) and written informed
consent was obtained from all study participants.
Laboratory measurements
Serum-free T4 (FT4), total T4, and total T3 concentra-
tions were measured by chemoluminescence assays
(Vitros ECI Immunodiagnostic System; Ortho-Clinical
Diagnostics, Rochester, MI). Serum TSH was measured
by immunometric assay (Immulite 2000 XPi, Siemens,
The Hague, the Netherlands).
Cardiac function
Transthoracic echocardiography using an iE33 Ultrasound
System (Philips Healthcare, Amsterdam, the Netherlands)
was performed by experienced technicians who were not
aware of the thyroid state of the subjects. Preload was
assessed before and after LT4 replacement through mea-
surements of left atrial volume (LAV) and left ventricular
end-diastolic volume (EDV), obtained with biplane Simp-
son’s method (TomTec Cardiac Performance Analysis,
Munich, Germany). The end-diastolic pressure (EDP) was
estimated using the Nagueh formula. Total afterload was
evaluated before and after LT4 replacement as the effective
arterial elastance (Ea) using available algorithms for nonin-
vasive PV analysis (Sunagawa et al. 1983; Chen et al. 2001).
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Systemic vascular resistance (SVR) was estimated as 80
(MAP - RAP)/CO, where RAP represents the Right atrial
pressure and CO the cardiac output. Contractility was rep-
resented by end-systolic pressure-volume relationship
(ESPVR) and chamber stiffness by the b coefficient, both
assessed using noninvasive PV analysis. To obtain the end-
systolic elastance (Ees), the elastance at mid-isovolumic
contraction (Ed) is derived using systolic time intervals and
the diastolic blood pressure. Subsequently, the estimated
value of Ed normalized to the end-systolic elastance was
calculated and used to derive the Ees. b was calculated using
a specific algorithm obtained from pressure and volume-
normalized EDPVRs obtained from 80 ex vivo human
hearts with different pathologies (Chen et al. 2001; Klotz
et al. 2006). Additional assessment of the cardiac function
included ejection fraction (EF), stroke volume (SV), and
cardiac power output (CPO), given by CPO=(MAP∙CO)/
451. Early and late transmitral inflow velocities (E and A
waves) and deceleration time (DET) were measured from
the mitral inflow pattern derived from the pulsed-wave
Doppler, from which the E/A ratio was calculated. Systolic
time intervals (isovolumic contraction time, ICT; and ejec-
tion time, ET) were obtained from tissue Doppler of the
medial mitral annulus and from pulsed Doppler of the LV
outflow tract, with end-systole set to the peak of the R-
wave. Ventricular-arterial coupling (VAC) was assessed by
means of the Ea/Ees ratio. Pressure-volume area (PVA) and
stroke work (SW), reflecting respectively the total energy
available for each cardiac cycle and the work done by the
ventricle to eject the stroke volume, were obtained. Their
ratio, reflecting the rate of PVA to SW conversion (work
efficiency fraction, WEF), was derived. The ratio of cardiac
output (CO) to PVA∙HR (to account for 1 min of PVA)
was compared prior and after treatment to evaluate the
effect of the chronotropic changes.
Statistical analysis
Data are expressed as median (IQR) or mean (SD) as
appropriate. Parametric data were compared with Student
t-tests and nonparametric data with Wilcoxon signed
rank tests between patients off and on LT4 treatment.
Spearman q was used to assess correlations between
changes in Ees and changes in TH levels. The R v3.3.3
package was applied with type I error set to 5%. Multi-
plicity corrections were not applied because this study
was exploratory and most of its variables are correlated
(Bender and Lange 2001; Schulz and Grimes 2005).
Results
Baseline characteristics are described in Table 1. Measure-
ments are described in Table 2 and Figure 1. As
anticipated, in deep hypothyroidism, T3 and FT4 were
significantly depressed while TSH was high. Heart rate
(HR) was significantly reduced pretreatment, as well as
SV (mean: 68  17 vs. 76  21 mL, P = 0.024).
During hypothyroidism, markers of preload (i.e., E-
wave velocity and filling volumes EDV and LAV) were
significantly reduced. Also, NT-pro-BNP levels were sig-
nificantly reduced. The E-wave was significantly lower but
the E/A and E/e0 ratios were unchanged, suggesting that
the reduced preload in hypothyroidism decreased the
magnitude of the mitral inflow.
Contractility was decreased in hypothyroidism, as the
Ees was significantly lower and the end-systolic pressure-
volume relationship (ESPVR) was shifted to the right and
downwards (Fig. 2). Ees showed a positive monotonic
correlation with FT4 levels (q = 0.59, P = 0.007) and
with T3 levels (q = 0.48, P = 0.03), as exhibited in Fig-
ure 3. Ejection fraction (EF) remained equivalent, while
CPO was significantly decreased pretreatment.
SVR was increased in hypothyroidism, but SBP was sig-
nificantly lower. As a consequence, the total afterload (Ea)
was not different from euthyroidism. Nevertheless, as
contractility was lower, the balance of forces favoring and
opposing blood ejection into the ascending aorta (VAC)
was significantly worse (i.e., <1.0) in the hypothyroid
state.
The PVA remained equal at beat level, but when
adjusted for HR, it was significantly lower in hypothy-
roidism. Work efficiency was also decreased as SW was
reduced and occupied a lower proportion of the total
energy available (WEF, SW/PVA ratio). This indicates less
mobilization of the myocardial energy. Conversely, the
SV/PVA ratio was unchanged suggesting that after correc-
tion, the fraction of SV displaced by 1J of PVA remained
the same.
Discussion
This is the first study measuring full-scale changes in the
cardiac function of patients with deep hypothyroidism
Table 1. Characteristics of study participants (n = 10). Data are
expressed as median (IQR) or as percentages.
Baseline characteristics
Female sex N (%) 6 (60)
Age (years) 43 (30–56)
Time between tests (weeks) 12 (11–16)
Dose LT4 (lg) 188 (150–225)
Dose LT4 (lg/kg) 2.1 (1.8–2.6)
BMI (kg/m²) 28.0 (23.0–31.8)
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versus high-normal thyroid states, applying noninvasive,
relatively load independent, PV analysis (Table 3). Previous
attempts to apply such techniques in this setting date back
to 1985 and 1988. Since then, PV theories have evolved
considerably. This study describes promising data and
introduces a new follow-up tool for thyroid disease that
calls for further confirmatory studies. LT4 supplementation
improved the hemodynamic profile and led to better ven-
tricular–arterial coupling by increasing preload and
contractility while keeping total afterload equal. Despite
improved efficiency at beat level, chronotropic increments
resulted in higher energetic costs in euthyroidism.
Global determinants of stroke volume
The three main determinants of SV consist of preload,
afterload, and contractility. During hypothyroidism, the
decreased LV and LA volumes in conjunction with lower
Table 2. Results (means  SD or medians  IQR as adequate).
Variable Hypothyroidism Euthyroidism P-value Normal values
Diastolic function
E-wave (cm/sec) 0.58  0.21 0.71  0.27 0.03 60–91
E/A 1.38  1.08 1.31  0.80 0.22 0.73–1.53
E/E0 8.18  2.45 8.82  1.45 0.48 <12
DET (msec) 195  56 196  72 0.54 138–219
DBP (mmHg) 83.20  9.70 79.10  7.81 0.26 60–89
EDV (mL) 122.6  32.49 135.7  33.59 <0.01 29–74
EDP (mmHg) 12.25  1.94 12.94  1.47 0.47 4–12
Systolic function
ICT (msec) 58 (49 to 68) 23 (19 to 28) <0.01 23–49
ET (msec) 262  29 282  23 <0.001 257–314
ICT/ET 0.20 (0.18 to 0.27) 0.08 (0.06 to 0.10) <0.01 0.07–0.17
SV (mL) 68  19 76  21 0.024 79–131
EF (%) 57  5 56  5 0.95 52–74
SBP (mmHg) 129 (117 to 137) 133 (127 to 141) 0.036 90–140
Global assessment
NT–pro–BNP (pg/mL) 1.0  0.0 6.0  4.0 0.01 <125
LAV (mL) 38.1  11.1 47.4  15.1 0.027 16–34
RAP (mmHg) 4 (3 to 5) 5 (5 to 5) 0.072 1 to 8
HR (bpm) 55.5  9.47 66.4  12.67 0.015 60–100
CPO (W) 1.5  0.34 2.09  0.57 <0.01 >0.6
SVR (dynsec/cm5) 1972  587.01 1626  446.48 <0.01 900–1400
Pressure-volume analysis
SW (J) 1.02  0.26 1.22  0.34 <0.01 No data
VAC 0.91 (0.79 to 1.32) 0.62 (0.57 to 0.68) 0.03 0.62–1.30
PVA (J) 1.56  0.39 1.70  0.49 0.15 No consensus
SV/PVA (mL/J) 42.88  7.98 44.34  6.54 0.5 No consensus
PVA∙HR (J/min) 86.86  28.02 110.89  32.05 0.04 No consensus
Ees (mmHg/mL) 1.70 (1.50 to 1.83) 2.58 (1.95 to 3.27) 0.01 2.0–4.0
Vo (mL) 12.9 (30.2 to 2.9) 10.0 (5.7 to 18.8) 0.01 No consensus
Ea (mmHg/mL) 1.66 (1.50 to 1.82) 1.79 (1.35 to 1.88) 0.43 1.4–3.0
WEF 0.68 (0.60 to 0.72) 0.76 (0.75 to 0.78) 0.01 No consensus
b 3.02  0.05 3.04  0.04 0.47 No consensus
Thyroid function
TSH (mU/L) 99.80 (75.25 to 130.50) 0.07 (0.02 to 0.20) <0.01 0.4–4.3
Free T4 (pmol/L) 1.3 (0.9 to 1.8) 32.0 (24.6 to 35.0) <0.01 11–25
T3 (nmol/L) 0.63  0.33 2.01  0.39 <0.01 1.4–2.5
Total T4 (nmol/L) 13  7 163  44 <0.01 58–128
E-top, early transmitral inflow velocity; A, late transmitral flow velocity; E0, early diastolic mitral annular velocity; DET, decelerating time; SBP,
systolic blood pressure; ICT, isovolumic contraction time; ET, ejection time; SV, stroke volume; EF, ejection fraction; DBP, diastolic blood pres-
sure; NT-pro-BNP, brain natriuretic peptide; EDV, end-diastolic volume; LAV, left atrial volume; RAP, right atrial pressure; HR, heart rate; CPO,
cardiac power output; SVR, systemic vascular resistance; SW, stroke work; VAC, ventricular–arterial coupling ratio; PVA, pressure-volume area;
Ees, end-systolic elastance; Vo, unstressed volume; Ea, arterial elastance; WEF, work efficiency fraction; b, chamber stiffness constant; TSH, thy-
roid-stimulating hormone.
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pro-BNP concentrations and lower passive mitral inflow
velocities indicate a reduction in preload, which is in line
with previous results (Buccino et al. 1967; Biondi et al.
2002). Afterload is a complex concept that is difficult to
evaluate in vivo. Several studies used different measure-
ment techniques, looking at the various components of the
total afterload. These approaches cannot be considered sep-
arately from other parameters (Chirinos and Segers 2010).
To exemplify, the diastolic aortic pressure opposes the start
of ejection, directly affecting systolic time intervals and
hence contractility (Hassan and Turner 1983). The distal
bed, mostly composed by small caliber vessels measuring
less than 500 lm diameter, can be better evaluated by the
SVR, which represents the steady component of the arterial
load (Nichols et al. 1977; Mitchell et al. 2001; Chirinos
et al. 2012). The aortic impedance reflects the pulsatile
component of the arterial load in the ascending aorta. The
total arterial compliance (TAC) responds for the pulsatile
component in the descending aorta, in large arteries, and
to a lesser degree in smaller vessels (Stergiopulos et al.
Figure 1. Comparison of hemodynamic variables (box plots) off and on T4. HR, heart rate; CO, cardiac output; EDV, end-diastolic volume;
LAV, left atrial volume; PVA, pressure-volume area; Ees, end-systolic elastance; SW, stroke work; WEF, work efficiency fraction; Ea, arterial
elastance; SV, stroke volume; TSH, thyroid-stimulating hormone; T4F, serum-free T4.
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1999). The total afterload denotes the summation of the
steady and pulsatile components.
Findings from PV analysis
Effective arterial elastance
Ea, the ratio between the end-systolic pressure (ESP) and
SV, has been proposed to represent the net arterial load
against which blood is ejected, thus reflecting the resul-
tant of the abovementioned variables. It has the advantage
of being readily comparable with the Ees, a measure of
contractility (Sunagawa et al. 1983; Klein and Ojamaa
2001). It can also be described as Ea = SVR/(60/
HR) + 0.42/C–0.04, where C represents TAC (Chemla
et al. 2003), showing significant agreement with the impe-
dance spectra. Ea integrates the two components of the
arterial load (Kelly et al. 1992). In the current study, LT4
supplementation reduced SVR without changing Ea and
DBP. This may reflect fluid retention and chronotropic
increments, turning the arterial system into a high impe-
dance hypocompliant compartment, and counterposing a
Figure 2. (A) Change in the systolic function. In hypothyroidism,
the ESPVR assumes a smaller slope indicating that the ventricles are
producing less pressure under the same ranges of volume. ESPVR
regression lines are derived from mean coefficients of Ees and Vo
and 95% confidence intervals. ESPVR, end-systolic pressure-volume
relationship. (B) Estimated pressure-volume loops summarizing
hemodynamic changes between the two states.
Figure 3. Analysis of correlations between Ees and thyroid
hormones. Ees, end-systolic elastance.
2018 | Vol. 6 | Iss. 19 | e13883
Page 6
ª 2018 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
The Physiological Society and the American Physiological Society
Hemodynamics in Hypothyroidism: A Pilot Study M. B. Bastos et al.
decreased steady component. The significantly increased
SBP, which is in consonance with this pattern, contributes
in keeping Ea constant.
Systolic time intervals
Hypothyroidism decreased contractility due to both lower
velocity of fiber shortening and lower systolic pressure
buildup. This is demonstrated by our findings that ICT
and Ees were significantly smaller and the ICT/ET ratio
was significantly higher in euthyroidism. These findings
are in line with previous studies comparing the pre-ejec-
tion period (PEP) with ET under different thyroid states
(Crowley et al. 1977). Of note, since the intraventricular
conduction times were statistically the same, this analysis
only applied the mechanical constituent of PEP (i.e.,
ICT).
Ventricular–arterial coupling and energetics
VAC, which represents the balance between contractility
and afterload, was significantly worse under hypothyroid
conditions. While maximal efficiency has reportedly been
linked to a ratio equal to or slightly below 1.0 (De Tombe
et al. 1993), our results demonstrate that LT4 treatment
facilitated the production of antegrade flow.
SW quantifies the conversion of chemomechanical energy
stored in the myocardium into hydraulic energy during each
heart cycle, while CPO predicts worse prognosis in heart fail-
ure when markedly reduced. Both measurements signifi-
cantly decreased in hypothyroidism. SW reduction was due
to decreases in both systolic pressure and SV.
At beat level, although the pressure-volume area (PVA)
was constant, WEF was higher in euthyroidism. This indi-
cates better mobilization of the metabolic and viscoelastic
energetic reserves at myocardial level at the same total
energetic cost. Contractility changes after LT4 replace-
ment are demonstrated by up-shifting of the ESPVR and
by a significant increment on the slope Ees. Although
increased contractility and SV would be expected to ele-
vate MVO2 at beat level, that did not happen possibly
due to the observed TH-mediated preload changes, which
may passively assist LV function, as previously postulated
(Biondi et al. 2002).
Higher values of WEF and increased SV occurred at
similar SV/PVA ratio indicating an improvement in both
work efficiency and flow production. Nevertheless, when
accounting for the increased HR, the net amount of
energy available during 1 min, estimated in joules of PVA
(PVA∙HR), was higher posttreatment. Hence, as a result
of the chronotropic response to TH, the efficiency gain
verified at beat level was not translated into a less energet-
ically costly cardiovascular state.T
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Strengths and limitations
Limitations of this study consist on small sample size,
shortness of exposure periods, and absence of tonomet-
ric measurements that would warrant a more precise
quantification of the pulsatile component of the after-
load. Also strain analysis was not possible. The study is
exploratory and its findings require further confirmation
prior to implementation in clinical practice. Strengths
consist in a fully integrated cardiac and global hemody-
namic assessment with well-established and state-of-the-
art tools, minimizing the bias derived from the varia-
tion in fluid status. In addition, the use of paired anal-
ysis to reduce confounding should be mentioned, as
well as the entirely noninvasive way of data collection
using dedicated echocardiography.
Conclusion
In conclusion, in patients with deep hypothyroidism, LT4
therapy increases contractility and preload, while the total
afterload remained constant. The new state was more
energetically efficient at beat level and theoretically
explains the increase in systolic pressures. Positive chron-
otropism, however, elevates CO and the net energetic cost
in 1 min. The results indicate for the first time that inte-
grated pressure-volume analysis can be noninvasively
applied in the follow-up of patients using levothyroxine.
A large-scale study screening patients with noninvasive
PV analysis on different phases of thyroid disease would
be desirable to characterize this technique as a predictive
tool for systolic dysfunction and other cardiovascular out-
comes. Also, a clearer demonstration of how the different
components of afterload would respond to TH would be
adequate. The obtained information should be useful for
tailoring therapeutics.
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